Fund | Company |
Abingworth Management | Chroma Therapeutics |
Advantage Capital Partners | Nascent Pharmaceuticals |
Advent Capital | Argonnex/Upstate |
Advent International | Stereotaxis |
Advent International | Stereotaxis |
Advent Venture Partners | Upstate |
Alafi Capital | Stereotaxis |
Alliance Technology Ventures | Discovery Therapeutics |
Athena Ventures | E-Site |
BioAdvance Greenhouse | Galleon Pharmaceuticals |
Bio-Star Ventures | Setagon |
BJC Health Systems | Stereotaxis |
Boston University Community Technology Fund | Insmed |
Brock Capital Group | NYVARRA |
Carillion Biomedical Institute | OcuCure Therapeutics |
CM Capital Limited | Cytogensis |
Columbia Capital LLC | Luna Technologies |
Crescendo Ventures | Elusys |
Eagle Advisors | Elusys |
EGS Healthcare Capital Partners | Stereotaxis |
Emerging Technology Partners | DirectGene |
Emerging Technology Partners | Adenosine Therapeutics |
Emerson | Stereotaxis |
Envest Ventures | Luna Technologies |
Essex Woodlands Health Ventures | Elusys |
Essex Woodlands Health Ventures | Chroma Therapeutics |
Gabriel Venture Partners | DirectGene |
General Catalyst | Avaki |
Gilde Healthcare | Chroma Therapeutics |
Glynn Ventures | Setagon |
Healthcare Ventures | Argonnex/Upstate |
IBM Venture Development | Avaki |
Intersouth Partners | Serenex |
Intersouth Partners | Insmed |
Invesco Private Capital | Elusys |
Legg Mason Emerald Fund | Elusys |
Lilly Ventures | Serenex |
Maverick Venture Management, LLC | MedQuest Products |
MDS Capital | MDS Proteomics |
Medimmune Ventures | Elusys |
Mediphase Venture Partners | Serenex |
NeuroVentures | Setagon |
Nomura Phase4 Ventures | Chroma Therapeutics |
Novak Biddle Venture Partners | Luna Technologies |
Novartis Venture Fund | DirectGene |
Polaris Venture Partners | Avaki |
Prolog Ventures | Stereotaxis |
RGGS Capital Partners | Argonnex/Upstate |
Sanderling Ventures | Stereotaxis |
Sanderling Ventures | Discovery Therapeutics |
Seaflower Ventures | Serenex |
Sofinnova Ventures | Avaki |
Soundview Ventures | Luna Technologies |
Stifel Nicolaus | Stereotaxis |
Takeda Research Investment | Serenex |
The Wellcome Trust | Chroma Therapeutics |
Venture Capital Partners | Insmed |